AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Athira Pharma, Inc. Director's Dealing 2022

Mar 21, 2022

35038_dirs_2022-03-21_40113f37-7182-42a1-b998-00246285d88c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2022-03-21

Reporting Person: PICKERING GRANT (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	783	Direct

Footnotes

F1: The shares were inadvertently omitted from Table I of the Form 3 originally filed on January 31, 2022.